Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Credit Rating

Anupam Rasayan India Credit Rating

CRISIL assigned 'Crisil A+' to Anupam Rasayan's ₹160 Crore NCDs and placed ₹1,620 Crore bank facilities on rating watch. This follows the acquisition of Bliss GVS Pharma.

Key figures
Value₹1,780 Cr
Source

BSE filing, NSE: ANURAS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Anupam Rasayan India Ltd: key numbers

Share price
₹1,151.40
Market cap
₹13,109 Cr
Revenue (annual)
₹2,365 Cr
Net profit (annual)
₹170.1 Cr
P/E (TTM)
75.0×Sector 34.1×
Promoter holding
59.07%+0.00% QoQ
FII holding
8.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Anupam Rasayan India Ltd

All →

Other credit rating announcements

All →